Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes
Open Access
- 24 October 2008
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 29 (11), 1273-1281
- https://doi.org/10.1002/humu.20889
Abstract
Locus‐specific databases (LSDBs) are curated collections of sequence variants in genes associated with disease. LSDBs of cancer‐related genes often serve as a critical resource to researchers, diagnostic laboratories, clinicians, and others in the cancer genetics community. LSDBs are poised to play an important role in disseminating clinical classification of variants. The IARC Working Group on Unclassified Genetic Variants has proposed a new system of five classes of variants in cancer susceptibility genes. However, standards are lacking for reporting and analyzing the multiple data types that assist in classifying variants. By adhering to standards of transparency and consistency in the curation and annotation of data, LSDBs can be critical for organizing our understanding of how genetic variation relates to disease. In this article we discuss how LSDBs can accomplish these goals, using existing databases for BRCA1, BRCA2, MSH2, MLH1, TP53, and CDKN2A to illustrate the progress and remaining challenges in this field. We recommend that: 1) LSDBs should only report a conclusion related to pathogenicity if a consensus has been reached by an expert panel. 2) The system used to classify variants should be standardized. The Working Group encourages use of the five class system described in this issue by Plon and colleagues. 3) Evidence that supports a conclusion should be reported in the database, including sources and criteria used for assignment. 4) Variants should only be classified as pathogenic if more than one type of evidence has been considered. 5) All instances of all variants should be recorded. Hum Mutat 29(11), 1273–1281, 2008. Published 2008 Wiley‐Liss, Inc.This publication has 39 references indexed in Scilit:
- Prediction and assessment of splicing alterations: implications for clinical testingHuman Mutation, 2008
- Assessment of functional effects of unclassified genetic variantsHuman Mutation, 2008
- Genetic evidence and integration of various data sources for classifying uncertain variants into a single modelHuman Mutation, 2008
- Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significanceHuman Mutation, 2008
- In silico analysis of missense substitutions using sequence-alignment based methodsHuman Mutation, 2008
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Recommendations for locus-specific databases and their curationHuman Mutation, 2007
- A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition GenesAmerican Journal of Human Genetics, 2007
- Novel biallelic mutations inMSH6 andPMS2 genes: gene conversion as a likely cause ofPMS2 gene inactivationHuman Mutation, 2007
- Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 2007